Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In the world economic growth, the Alpha Glucosidase Inhibitors Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Alpha Glucosidase Inhibitors market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Alpha Glucosidase Inhibitors market size will be further expanded, we expect that by 2024, The market size of the Alpha Glucosidase Inhibitors will reach XXX million $.
Alpha Glucosidase Inhibitors Market Overview
Alpha-glucosidase inhibitors (AGIs) are anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates. Alpha-glucosidase inhibitors help to absorb carbohydrates by breaking down the same into small sugar molecules of glucose. This inhibition is reversible and competitive in nature. The global alpha glucosidase inhibitors market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global alpha glucosidase inhibitors market is expected to witness significant growth during the forecast period, owing to rising geriatric population worldwide.
Alpha Glucosidase Inhibitors Market Drivers
Increasing prevalence of type 2 diabetes worldwide is expected to drive growth of the global alpha glucosidase inhibitors market during the forecast period. According to the International Diabetes Federation (IDF), in 2019, around 463 million adults aged between 20 and 79 years were living with diabetes. According to the same source, around 374 million people are at increased risk of developing type 2 diabetes. Alpha-glucosidase plays a crucial role in inhibiting type 2 diabetes, which in turn, is expected to drive growth of the global alpha glucosidase inhibitors market during the forecast period. Furthermore, increasing geriatric population and rising disposable incomes is expected to propel the global alpha glucosidase inhibitors market growth over the forecast period. According to the United Nations (UN), the global population aged 60 years and above were numbered at 962 million in 2017 and will reach 2.1 billion by 2050.
Alpha Glucosidase Inhibitors Market Restraint
Side-effects such as loose stools and flatulence are expected to hamper the global alpha glucosidase inhibitors market growth over the forecast period.
Regional Insights
Among regions, North America is expected to witness significant growth in the global alpha glucosidase inhibitors market during the forecast period. This is owing to rising prevalence of type 2 diabetes across the region. Furthermore, Europe is expected to exhibit a lucrative growth rate over the forecast period, owing to rising disposable income and increasing investments in research and development activities in the region.
Competitive Section
Key companies involved in the global alpha glucosidase inhibitors market are Pfizer, Unichem, Bayer Pharma, Hexalag, Takeda, Torrent, Sun Pharma, and Glenmark Pharma.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
➟ Pfizer
➟ Bayer pharma
➟ Takeda
➟ Sun pharma
➟ Glenmark pharma
➟ Torrent
➟ Hexalag
➟ Unichem
Section 4: Region Segmentation
➟ North America Country (United States, Canada)
➟ South America
➟ Asia Country (China, Japan, India, Korea)
➟ Europe Country (Germany, UK, France, Italy)
➟ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Segmentation
Product Type Segmentation:
➟ Dumping Syndrome
➟ Type 2 Diabetes
Industry Segmentation:
➟ Online Pharmacies
➟ Retail Pharmacies
➟ Hospital Pharmacies
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
